Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

计划入组 18 人 · 首次发布于 2005 年 5 月 11 日

Belgian Antithrombin Deficiency Registry

计划入组 1,000 人 · 首次发布于 2023 年 6 月 7 日

A Study of KW-3357 in Congenital Antithrombin Deficiency

计划入组 16 人 · 首次发布于 2009 年 7 月 13 日

Antithrombin Alfa(Atryn)

Antithrombin III human(Thrombate III)

Antithrombin gamma

Rockwell Medical

United States

Biora Therapeutics

United States

Astria Therapeutics Inc

United States

FDA Approves First Antithrombin Concentrate for Pediatric Patients with Hereditary Antithrombin Deficiency

Fitusiran Demonstrates Efficacy in Hemophilia A and B with Reduced Factor Consumption

NTLA-2002 Demonstrates Significant Reduction in Angioedema Attacks via CRISPR-Cas9 Gene Editing